The legal battle over Johnson & Johnson’s talcum powder products continues to unfold in courtrooms across the United States. Tens of thousands of women have filed lawsuits alleging that long-term use of Johnson’s® Baby Powder and Shower to Shower® caused them to develop ovarian cancer, due to asbestos contamination in the talc. As of July 2025, the litigation remains active, with new cases being filed, bellwether trials scheduled, and settlement negotiations underway.
This article provides a comprehensive update on the current status of the lawsuits, key developments in the multidistrict litigation (MDL), and what plaintiffs and their families can expect next.
Overview of the Litigation
More than 63,000 lawsuits have been filed against Johnson & Johnson (J&J) in MDL No. 2738, consolidated in the U.S. District Court for the District of New Jersey2. Plaintiffs allege that J&J’s talc-based products were contaminated with asbestos and that the company failed to warn consumers of the cancer risks.
The litigation includes claims for:
- Ovarian cancer linked to long-term genital use of talcum powder
- Wrongful death filed by surviving family members
- Punitive damages for alleged corporate misconduct
July 2025 Status: Key Updates
1. First Bellwether Trial Selected
The first bellwether trial in the MDL has been selected: Judkins v. Johnson & Johnson, filed by a New Hampshire woman who developed ovarian cancer after decades of talc use. Her case will serve as a test trial to gauge jury response and influence future settlement negotiations.
- Plaintiff began using Johnson’s Baby Powder in 1971
- Diagnosed with ovarian cancer in 2016
- Trial expected to begin later in 2025
Bellwether trials are critical in mass tort litigation, as they help both sides assess the strength of their arguments and the potential value of claims.
2. Court-Appointed Mediator
In early July, the MDL judge appointed Fouad Kurdi of Resolutions LLC as the official mediator to oversee settlement discussions4. Both plaintiffs and defendants are required to participate in good faith.
While Johnson & Johnson has expressed skepticism about mediation, the court’s move signals a renewed push toward a global resolution.
3. Bankruptcy Strategy Rejected
Johnson & Johnson’s third attempt to resolve the lawsuits through bankruptcy was rejected by a federal judge in April 20254. The company had proposed an $8.9 billion settlement through a subsidiary, Red River Talc, but the court found the plan lacked sufficient support and fairness.
- J&J confirmed it will not appeal the ruling
- Litigation has resumed in federal and state courts
- New cases continue to be filed monthly
This decision marks a turning point, as plaintiffs can now pursue their claims without the delays and limitations of bankruptcy proceedings.
Recent Verdicts and Settlements
While most ovarian cancer cases remain pending, several verdicts and settlements have shaped the litigation landscape:
- $4.69 billion – Missouri jury awarded damages to 22 women with ovarian cancer (2018)
- $417 million – Los Angeles verdict for ovarian cancer (2017)
- $700 million – Multistate deceptive marketing settlement finalized in 2024
These outcomes demonstrate the courts’ willingness to hold J&J accountable and award substantial compensation to victims.
What Plaintiffs Can Expect Next
1. Increased Trial Activity
With bankruptcy off the table, courts are preparing for bellwether trials and individual case proceedings. Plaintiffs should expect:
- Discovery and expert testimony
- Pretrial motions and hearings
- Settlement offers or trial scheduling
State courts, including those in Philadelphia and California, are also setting trial dates for ovarian cancer claims.
2. Renewed Settlement Negotiations
The appointment of a mediator suggests that the court is serious about exploring a global settlement. Plaintiffs may receive structured offers based on:
- Diagnosis and severity
- Duration of talc use
- Age and medical history
- Economic and non-economic damages
Settlement amounts may range from $100,000 to $500,000 or more, depending on individual circumstances.
3. Continued Case Filings
New ovarian cancer claims are being filed every month. As of July 2025, the MDL has added over 1,000 new cases in the past 30 days. This growth reflects ongoing public awareness and legal momentum.
How to File a Claim
If you or a loved one developed ovarian cancer after using talcum powder, you may still be eligible to file a lawsuit. Here’s how:
Step 1: Consult a Talc Litigation Attorney
Choose a lawyer experienced in mass torts and product liability. Most offer free consultations and work on a contingency basis.
Step 2: Gather Evidence
Your attorney will help collect:
- Medical records and pathology reports
- Product usage history
- Witness statements
- Expert testimony
Step 3: File Before the Deadline
Each state has its own statute of limitations, typically 1 to 3 years from diagnosis or discovery of harm. Filing promptly is essential.
Final Thoughts
The Johnson & Johnson ovarian cancer lawsuits are entering a critical phase. With bankruptcy efforts rejected, bellwether trials scheduled, and settlement talks underway, plaintiffs have a renewed opportunity to pursue justice and compensation.
If you or a family member used talcum powder and later developed ovarian cancer, now is the time to act. A qualified attorney can help you understand your rights, build a strong case, and join thousands of others seeking accountability from one of the world’s largest healthcare companies.
References
- Talc Baby Powder Lawsuit | July 2025 Settlement Update – Lawsuit Information Center
- Talcum Powder Lawsuit Update | 2025 Status & Settlements – LawFirm.com
- Talcum Powder Lawsuit Updates & Latest News – Sokolove Law
- Talcum Powder Lawsuit: Cancer Claims & Eligibility – Drugwatch